Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Little sedi action.

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Feb 28, 2023 6:29am

135 Views

Post# 35308835

RE:RE:RE:RE:RE:RE:Little sedi action.

Hi Fox, difficult time! We share the same feeling. I can understand the secret when negociations are on but... In a way the very long shareholders deserve to know something. I'm about to sell a part of my holding, if no positive sigh show up in a week or two! Friday we will have nothing new from Matt? Hope for some positive sentences but not holding my breath. Time to sell this tiny company and product to a BP with money and a big team to push this product out. Matt wake up! the value of your product at this stage of development is probably closer to 2B not 10B! GLTAL

<< Previous

Bullboard Posts

Next >>

Under Bitcoin's shadow: A survey of Ethereum ETFs in Canada